Table 1.
Resistance to First- and Second - Line Tuberculosis Drugs in New and Previously treated Cases
| Resistance | N=605 | Total N=605 (100%) |
||
|---|---|---|---|---|
| New cases n=222 (36,7%) |
Previously treated Cases n=383 (63,3%) |
|||
| Sensitive TB | 73 (32,88%) | 41 (10,70%) | 114 (18,8%) | |
| Total DR-TB | 149 (67,12%) | 342 (89,30%) | 491(81,2%) | |
| Resistance for I Line TB Drugs | ||||
| Total Mono DR-TB | 69 (31,08%) | 61 (15,93%) | 130 (21,5%) | |
| H | 8 (3,6%) | 12 (3,13%) | 20 (3,3%) | |
| R | 1 (0,45%) | 3 (0,8%) | 4 (0,7%) | |
| S | 60 (27,03%) | 45 (11,75%) | 105 (17,3%) | |
| E | 0 | 1 (0,3%) | 1 (0,2%) | |
| Total PDR-TB | 23 (10,36%) | 44 (11,5%) | 67 (11,1%) | |
| H+S | 19 (8,6%) | 33 (8,62,%) | 52 (8,6%) | |
| H+E | 0 | 0 | 0 | |
| R+S | 2 (0,9%) | 3 (0,8%) | 5 (0,8%) | |
| R+E | 0 | 1 (0,3%) | 1 (0,2%) | |
| S+E | 1 (0,45%) | 2 (0,52%) | 3 (0,5%) | |
| H+S+E | 0 | 4 (1,04%) | 4 (0,7%) | |
| R+S+E | 1 (0,45%) | 1 (0,3%) | 2 (0,3%) | |
| Total MDR-TB | 51 (22,97%) | 210 (54,83%) | 261 (43,1%) | |
| H+R | 2 (0,9%) | 13 (3,4%) | 15 (2,5%) | |
| H+R+S | 26 (11,71%) | 85 (22,2%) | 111 (18,3%) | |
| H+R+E | 0 | 7 (1,83%) | 7 (1,2%) | |
| H+R+S+E | 23 (10,36%) | 105 (27,4%) | 128 (21,1%) | |
| Resistance for II Line TB Drugs | ||||
| Amk | 11 (4,95%) | 43 (11,23%) | 54 (8,9%) | |
| Cm | 12 (5,4%) | 39 (10,18%) | 51 (8,4%) | |
| Ofx | 14 (6,3%) | 61 (15,93%) | 75 (12,4%) | |
| Eto | 37 (16,7%) | 104 (27,15%) | 141 (23,3%) | |
| Cs | 11 (4,95%) | 37 (9,66%) | 48 (7,9%) | |
| PAS | 10 (4,5%) | 26 (6,8%) | 36 (6,0%) | |
| Total XDR-TB | 6 (2,70%) | 27 (7,04%) | 33 (5,5%) | |